BOARD OF DIRECTORS & INVESTORS Supporting bold initiatives

Board of Directors

Vincent Fert (Chairman)

Bervin Bouani (Director, SHAM representative)

Corinne Danan (Director)

Stephane Debono (Director)

Philippe Dhamelincourt (Director, MI Care representative)

Olivier Martinez (Director, Bpifrance representative)

Katya Smirnyagina (Director, Quest for Growth representative)


Audrey Boccadifuoco (Observer, SOFIPACA representative)

Luc Pascal (Observer, BNP Paribas Developpement representative)

Michel Pourcelot (Observer, SOFIPACA representative)

Christophe Somaini (Observer, Amundi Private Equity Funds representative)


In 2015, HalioDx has completed a Round A of financing of 8.5 million euros combining the founders and leading capital venture funds : MI Care S.A., SHAM Innovation Santé advised by Turenne Capital, Sofipaca and BNP Paribas Développement.

In 2018, HalioDx has completed a Round B of financing of 18.5 million euros combining 3 new investors PSIM fund managed by Bpifrance, Amundi Private Equity Funds and Quest for Growth managed by Capricorn venture Partners, with the 4 historical investors : MI Care S.A., Sham Innovation Santé/Turenne, BNP Paribas Développement and Sofipaca.